Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
about
Recent advances in multiple myeloma: a Korean perspectiveImpact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma.Bone marrow plasma cell assessment before peripheral blood stem cell mobilization in patients with multiple myeloma undergoing autologous stem cell transplantation.Predictive value of post-transplant bone marrow plasma cell percent in multiple myeloma patients undergone autologous transplantation.Complete response after autologous stem cell transplant in multiple myelomaHaematopoietic stem cell transplantation as first-line treatment in myeloma: a global perspective of current concepts and future possibilitiesLong-term outcomes of different bortezomib-based regimens in Chinese myeloma patients.Early response to bortezomib combined chemotherapy can help predict survival in patients with multiple myeloma who are ineligible for stem cell transplantation.The impact of novel therapeutic agents before and after frontline autologous stem cell transplantation in patients with multiple myelomaMultiple myeloma preparative regimens for high-dose therapy and autologous transplantation: what's new?Controversies in the assessment of minimal residual disease in multiple myeloma: clinical significance of minimal residual disease negativity using highly sensitive techniques.Modified CVAD and modified CBAD compared to high-dose cyclophosphamide for peripheral blood stem cell mobilization in patients with multiple myeloma.Association between complete response and outcomes in transplant-eligible myeloma patients in the era of novel agents.Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF.Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation.Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working Group.CR represents an early index of potential long survival in multiple myeloma.Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma.
P2860
Q28074521-13356A72-4312-4A2E-822F-F78F5BF87225Q30301228-16965DC0-02A7-4020-BAFC-7A9CC0C33EBCQ33660396-DE881A3F-7E26-462D-B80A-B56861E3DFCCQ34665449-F7EB7BD8-5DBF-4707-8E8B-7EB59B5A6CFEQ35000475-9115F771-D356-4F45-B14A-7B3BDF656BC0Q35569350-951AE1C6-7850-49B6-BF63-17145BA1DC17Q36525841-E8FB8790-184C-440F-B5BE-7D56DBF6E024Q36536365-F49511F3-10B7-457F-A687-782F40E56677Q37205591-0B647BDF-985F-4E81-9BFC-B28687DEA9B8Q38163027-CD697B14-5267-44E3-BF7D-4F8749FA3917Q38249930-B15C7066-BE26-4AC3-B7C9-F3617AEA7E3AQ39051472-912D476F-F4EC-4137-BF48-82AAC8A14DD1Q40469944-F6390574-D083-4077-9DFA-6604681298CDQ41274044-8DF6FBFB-3FD5-457D-B13D-CD337EA1EB06Q47409821-67DF4C9B-0CEB-4A85-A3B9-8C52F96A6960Q48848774-6E206A90-BBCC-46AF-A4C7-0F673D2A2AF2Q49184612-F64D24D8-89C8-41D3-8326-0D28F4BD7D55Q52860687-E37B2FA0-12C2-4163-B59D-FFB54F2650FA
P2860
Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Complete remission status befo ...... le autologous transplantation.
@en
Complete remission status befo ...... le autologous transplantation.
@nl
type
label
Complete remission status befo ...... le autologous transplantation.
@en
Complete remission status befo ...... le autologous transplantation.
@nl
prefLabel
Complete remission status befo ...... le autologous transplantation.
@en
Complete remission status befo ...... le autologous transplantation.
@nl
P2093
P1476
Complete remission status befo ...... gle autologous transplantation
@en
P2093
Cheolwon Suh
Deog Yeon Jo
Hun Mo Ryoo
Jae Hoon Lee
Jin Seok Kim
Kihyun Kim
Korean Multiple Myeloma Working Party
Sung Soo Yoon
P304
P356
10.1016/J.BBMT.2008.12.512
P577
2009-04-01T00:00:00Z